Ipriflavone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Ipriflavone is a synthetic isoflavone which may be used to inhibit bone resorption,[1] maintain bone density and to prevent osteoporosis in postmenopausal women. It is not used to treat osteoporosis. It slows down the action of the osteoclasts (bone-eroding cells), possibly allowing the osteoblasts (bone-building cells) to build up bone mass.
A clinical trial reported in 2001 that it was not effective in prevention or treatment of osteoporosis.[2]
A double-blind study reveals that ipriflavone might be effective on reducing tinnitus on otosclerosis sufferers.[3]
References
References
- ↑ Civitelli, R. (1997). “In Vitro and in Vivo effects of ipriflavone on bone formation and bone biomechanics”. Calcified Tissue International. 61: S12–4. doi:10.1007/s002239900378. PMID 9263610.
- ↑ Alexandersen, P.; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY; Ipriflavone Multicenter European Fracture Study (2001). “Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial”. JAMA. 285 (11): 1482–8. doi:10.1001/jama.285.11.1482. PMID 11255425.
- ↑ Sziklai, I; Komora, V; Ribári, O (1992). “Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis”. Acta chirurgica Hungarica. 33 (1–2): 101–7. PMID 1343452.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH